Listen to Stockhead’s resident Health and Biotech expert Tim Boreham discuss Cynata with CEO Dr Ross Macdonald
Here is the interview
Read an article published in BioProcess International which explores Cynata’s interest in this area.
Finance News Network discusses with Cynata CEO Dr Ross Macdonald the Company’s 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company's Cymerus cell therapy platform
Ed Miseta, Clinical Leader’s Chief Editor, discusses Cynata’s osteoarthritis clinical program and general therapeutic stem cell topics with Cynata’s CEO, Dr Ross Macdonald and COO, Dr Kilian Kelly.